Dynamic changes of throat swabs RNA and serum antibodies for SARS-CoV-2 and their diagnostic performances in patients with COVID-19

被引:6
|
作者
Qiu, Xueping [1 ,2 ]
Xiang, Yang [1 ,2 ]
Sun, Jianbin [3 ]
Wang, Xinrui [4 ]
Chen, Guoqiang [5 ]
Xu, Xianqun [1 ,2 ]
Liao, Shengjun [1 ,2 ]
Yang, Na [1 ,2 ]
Li, Siwei [1 ,2 ]
Yang, Gang [1 ,2 ]
Tang, Yueting [1 ,2 ]
Fan, Junli [1 ,2 ]
Xie, Wen [1 ,2 ]
Hu, Hanning [1 ,2 ]
Li, Yirong [1 ,2 ]
Zheng, Fang [1 ,2 ]
机构
[1] Wuhan Univ, Zhongnan Hosp, Ctr Gene Diag, Donghu Rd 169, Wuhan 430071, Peoples R China
[2] Wuhan Univ, Zhongnan Hosp, Dept Lab Med, Donghu Rd 169, Wuhan 430071, Peoples R China
[3] Wuhan Univ, Tongren Hosp, Wuhan Hosp 3, Wuhan, Peoples R China
[4] Hebi City Ctr Dis Control & Prevent, Hebi, Peoples R China
[5] Huang Gang Cent Hosp, Huang Gang, Peoples R China
关键词
Antibody; SARS-CoV-2; COVID-19; RNA; throat swabs; HOSPITALIZED-PATIENTS; CORONAVIRUS; WUHAN;
D O I
10.1080/22221751.2020.1810133
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Dynamic changes of RNA and antibodies in SARS-CoV-2 infected patients remain largely unknown, and influence factors for antibody production have not been fully clarified. In this study, consecutive throat swabs specimens (n = 1875) from 187 patients were collected to analyse the dynamic changes of RNA. Moreover, 162 serial serum samples from 31 patients were tested for seroconversion of IgM and IgG. Meanwhile, IgM and IgG were also detected in 409 COVID-19 patients and 389 controls. Additionally, the logistic regression analysis was executed to identify the possible influence factors for antibody production. The median positive conversion time for RNA was day 7 (IQR, 3-11), and the positive rate was highest in day 1-5 (74.59 %) and then gradually decreased. The median time of seroconversion for IgM and IgG were both day 12 (IQR, 10-15). The sensitivity and specificity for IgM (or IgG) was 87.04% and 96.92%, respectively. Multivariate logistic regression indicated that reduced lymphocytes and short positive conversion time for SARS-CoV-2 RNA were independent factors for negative results of IgM and IgG. In conclusion, RNA and antibodies should be combined for COVID-19 diagnosis, and delayed seroconversion was influenced by the decreased lymphocytes and short positive conversion time for RNA.
引用
下载
收藏
页码:1974 / 1983
页数:10
相关论文
共 50 条
  • [41] IMMUNITY TO COVID-19 AND ISSUES OF SCREENING FOR SARS-COV-2 ANTIBODIES
    Mayanskiy, N. A.
    BULLETIN OF RUSSIAN STATE MEDICAL UNIVERSITY, 2020, (03): : 25 - 27
  • [42] SARS-CoV-2 Neutralizing Antibodies for COVID-19 Prevention and Treatment
    Li, Dapeng
    Sempowski, Gregory D.
    Saunders, Kevin O.
    Acharya, Priyamvada
    Haynes, Barton F.
    ANNUAL REVIEW OF MEDICINE, 2022, 73 : 1 - 16
  • [43] Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection
    Yu-Chyi Hwang
    Ruei-Min Lu
    Shih-Chieh Su
    Pao-Yin Chiang
    Shih-Han Ko
    Feng-Yi Ke
    Kang-Hao Liang
    Tzung-Yang Hsieh
    Han-Chung Wu
    Journal of Biomedical Science, 29
  • [44] Traces of SARS-CoV-2 RNA in Peripheral Blood Cells of Patients with COVID-19
    Moustafa, Ahmed
    Khalel, Rana Salah
    Aziz, Ramy K.
    OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 2021, 25 (08) : 475 - 483
  • [45] Persistent detection of SARS-CoV-2 RNA in patients and healthcare workers with COVID-19
    Gombar, Saurabh
    Chang, Marcello
    Hogan, Catherine A.
    Zehnder, James
    Boyd, Scott
    Pinsky, Benjamin A.
    Shah, Nigam H.
    JOURNAL OF CLINICAL VIROLOGY, 2020, 129
  • [46] Persistence of SARS-CoV-2 RNA in Gastrointestinal Tissues from COVID-19 Patients
    Saberi, Shahram
    Hoskoppal, Deepthi
    Chiriboga, Luis
    Zhao, Chaohui
    Sarkar, Suparna
    Cao, Wenqing
    LABORATORY INVESTIGATION, 2023, 103 (03) : S625 - S626
  • [47] SARS-CoV-2 and Microbiological Diagnostic Dynamics in COVID-19 Pandemic
    Erensoy, Selda
    MIKROBIYOLOJI BULTENI, 2020, 54 (03): : 497 - 509
  • [48] Progress in SARS-CoV-2, diagnostic and clinical treatment of COVID-19
    Li, Yang
    Lu, Si-Ming
    Wang, Jia-Long
    Yao, Hang-Ping
    Liang, Li Guo
    HELIYON, 2024, 10 (12)
  • [49] ESCMID COVID-19 guidelines: diagnostic testing for SARS-CoV-2
    Fragkou, Paraskevi C.
    De Angelis, Giulia
    Menchinelli, Giulia
    Can, Fusun
    Garcia, Federico
    Morfin-Sherpa, Florence
    Dimopoulou, Dimitra
    Mack, Elisabeth
    de Salazar, Adolfo
    Grossi, Adriano
    Lytras, Theodore
    Skevaki, Chrysanthi
    CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (06) : 812 - 822
  • [50] The role of serum specific- SARS-CoV-2 antibody in COVID-19 patients
    Chen, Hao
    Zhang, Xinyu
    Liu, Wanjun
    Xue, Mingshan
    Liao, Chenxi
    Huang, Zhifeng
    Hu, Haisheng
    Sun, Baoqing
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 91